CLINICAL SCIENCE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2020-11-29 147a3635m20暂无昵称

八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。

129 0

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2020-07-01 12.17

审稿速度:1.0 | 投稿命中率:50.0
经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。

138 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-08-05 1de14753m02(暂无匿称)

审稿速度:1.0 | 投稿命中率:25.0
经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！

176 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-03-23 雪山飞蚊

很快就收到revise的邮件了kelly1 2019-03-21 发表::
请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表:
请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？

kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？

215 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-03-21 kelly1

请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？

176 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2020-08-12 88559297_37710376

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床;基础
经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！

134 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-10-31 鱼来

请问各位大神，质检通过后，多久assign ？

163 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2020-07-10 薛定谔的猫饼

审稿速度:2.0 | 投稿命中率:50.0
经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。

99 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-10-05 472795

大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=903353, encodeId=c707903353e2, content=八月中旬投稿，送审25天之后返回意见，两个审稿人意见比较积极，但编辑给了拒搞重投。按意见修改后9月底重新投稿，十月中旬修回，编辑给的小修。十一月重新返修，月底接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21665232606, createdName=147a3635m20暂无昵称, createdTime=Sun Nov 29 18:59:05 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=800767, encodeId=8ee1800e674f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：看到大家都说很难中，就心惊胆战的投了稿。第一次投稿时，由于其中一个审稿人列出了很多意见，编辑让修改后重投，重新投稿后还是原来的审稿人审的，9天就审完了，给了小修意见，修改后再提交直接接收，一周内见刊。杂志对临床标本和动物造模的方法学要求很高。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://q.qlogo.cn/qqapp/101296147/956562A6F0D877680D4FFBCDFE6C84CF/100, createdBy=40fb1970149, createdName=12.17, createdTime=Wed Jul 01 14:18:04 CST 2020, time=2020-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574450, encodeId=91ae5e44501b, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：投过去十天左右送审，二十多天一审结束，一个reviewer几乎同意，一个大修，编辑给了大修意见，好多没法补实验，诚恳的回答了问题，两周后修回，第二个reviewer也几乎同意，再让加几篇参考文献，编辑给了小修，一天后修回，一周左右接收！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fe1d1672319, createdName=1de14753m02(暂无匿称), createdTime=Mon Aug 05 00:00:00 CST 2019, time=2019-08-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568490, encodeId=7c9b568490d9, content=很快就收到revise的邮件了kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？kelly1 2019-03-21 00:00:00 发表: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=kelly1 2019-03-21 发表:: 请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=215, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/16/8f5017fb05bf69718fdf7eed4212be82.jpg, createdBy=ad412230135, createdName=雪山飞蚊, createdTime=Sat Mar 23 00:00:00 CST 2019, time=2019-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568392, encodeId=8f00568392ef, content=请问各位前辈，投稿状态变成manuscript revise and re-review和 in review ，可是通讯作者没有收到revise的邮件，是稿件又重新审稿的意思吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eq5365ZIwVFF3fdGPFjvt1KLY710fxy1Cjicem9UL0T31lmaVibwA75xszibg4DWnj8oUd0o74WJpR1A/132, createdBy=c47c14204, createdName=kelly1, createdTime=Thu Mar 21 00:00:00 CST 2019, time=2019-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807684, encodeId=629a80e6844f, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床;基础 经验分享：现在投稿，需要原始WB图。。一般投稿到副主编要几天，现在送审中。祝我好运！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=47c02480649, createdName=88559297_37710376, createdTime=Wed Aug 12 09:37:32 CST 2020, time=2020-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579103, encodeId=ec0c5e9103aa, content=请问各位大神，质检通过后，多久assign ？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=163, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/a0e1281e4c337e3a6eccdb7345568930.jpg, createdBy=fb782481083, createdName=鱼来, createdTime=Thu Oct 31 00:00:00 CST 2019, time=2019-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802037, encodeId=393080203ee6, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：投稿—送审-拒稿重投-按意见补实验-重投并要求同样的专家审稿-小修-接收。其中一个专家要求补临床实验。无版面费。有漂亮的图还是很容易选上封面的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/KWHUk3wibwmnKBuFaicibDj74QJvZKBRriclEFbaSNshhxx309Owps0lhjrhDCmFHicFDyAtfjEAuReXZu7ddwXz1yQ/132, createdBy=be1b2445202, createdName=薛定谔的猫饼, createdTime=Fri Jul 10 11:06:02 CST 2020, time=2020-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577321, encodeId=ed425e732144, content=大家注意这个杂志坑人，2年投一稿，2月后问，居然说稿件丢了。最近投一稿，两个审稿人都是积极的评论，有一个审稿人说录用了要写一个评论。用了4个多月回答了所有问题，并补充了较多的实验。编辑居然又找了一个完全不懂这个领域的审稿人乱说一通拒稿了。令人吐血。大家千万要慎重，这种极不负责的杂志会让你毕不了业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45281422862, createdName=472795, createdTime=Sat Oct 05 00:00:00 CST 2019, time=2019-10-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855016, encodeId=f51985501697, content=审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=034d5414059, createdName=ms9701686724742584, createdTime=Sat Nov 16 18:22:26 CST 2019, time=2019-11-16, status=1, ipAttribution=)]

2019-11-16 ms9701686724742584

审稿速度较慢，一审二审都是3个多月，好处是只要催了就给消息，2次修稿后接受。可以接受基础研究的论文，但是研究必须要有临床价值。审稿人比较专业，提的问题也挺多。

104 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务